指南与共识冠心病血脂与心血管预防

2023 AHA/ACC等慢性冠心病管理指南

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
指南 / 共识 · Circulation · 2023-07-20

该指南更新并整合了自2012年稳定缺血性心脏病指南及2014年聚焦更新以来的新证据,采用以患者为中心、考虑健康社会决定因素的方法管理慢性冠心病,涵盖抗症状治疗、事件预防、血运重建决策、特殊人群管理及随访监测等。

要点

  • 指南强调以患者为中心、共享决策和团队护理。
  • 提供减少症状和未来心血管事件的指南导向管理推荐。
  • 包含慢性冠心病血运重建决策及特殊人群管理建议。

核心结论

  • 指南为慢性冠心病患者提供了基于证据且以患者为中心的管理方法。

研究设计与样本

  • 制定机构包括AHA、ACC、ACCP、ASPC、NLA和PCNA,综合检索2021年9月至2022年5月文献。

关键数值与推荐

  • 推荐考虑健康社会决定因素,并融入共享决策和团队护理原则。
  • 涵盖一般治疗决策、指南导向管理与治疗、血运重建决策、特殊人群管理及随访监测。

临床怎么用

  • 临床医生应依据指南推荐,结合患者社会因素和偏好制定个体化治疗方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: The "2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease" provides an update to and consolidates new evidence since the "2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease" and the corresponding "2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease." METHODS: A comprehensive literature search was conducted from September 2021 to May 2022. Clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants were identified that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. STRUCTURE: This guideline provides an evidenced-based and patient-centered approach to management of patients with chronic coronary disease, considering social determinants of health and incorporating the principles of shared decision-making and team-based care. Relevant topics include general approaches to treatment decisions, guideline-directed management and therapy to reduce symptoms and future cardiovascular events, decision-making pertaining to revascularization in patients with chronic coronary disease, recommendations for management in special populations, patient follow-up and monitoring, evidence gaps, and areas in need of future research. Where applicable, and based on availability of cost-effectiveness data, cost-value recommendations are also provided for clinicians. Many recommendations from previously published guidelines have been updated with new evidence, and new recommendations have been created when supported by published data.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Virani, Newby, Arnold, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023. PMID: 37471501. doi:10.1161/CIR.0000000000001168

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。